Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma

NCT00554905 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT00554905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00554905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Lead sponsor
Sun Yat-sen University
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2006
Completion date
June 30, 2009
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, liver cancer